Recombinant Anti-CTLA4 x Anti-PD1 Bispecific Antibody (Fv-IgG) is an appended IgG format, which has 2+2 antigen-binding valency. This dual variable domain IgG is generated by appending variable domains of an anti-CTLA4 IgG with similar domains from an anti-PD1 antibody via short peptide linkers, or vice versa. This BsAb can bind two factors simultaneously and enhance immune response. It is designed for the research of Tumors therapy.
There are currently no customer reviews or questions for Recombinant Anti-CTLA4 x Anti-PD1 Bispecific Antibody (Fv-IgG) (BSDG-146). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS